Thieme E-Books & E-Journals -
Back
Pharmacopsychiatry 2008; 41(6): 232-239
DOI: 10.1055/s-0028-1082072
Original Paper

© Georg Thieme Verlag KG Stuttgart · New York

A Double-blind Placebo-controlled Discontinuation Study of Zuclopenthixol for the Treatment of Aggressive Disruptive Behaviours in Adults with Mental Retardation – Secondary Parameter Analyses

F. Häßler 1 , T. Glaser 2 , A. F. Pap 2 , M. Beneke 2 , A. Diefenbacher 3 , O. Reis 1 and the Zuclopenthixol Disruptive Behaviour Study Group
  • 1Clinic for Child and Adolescent Psychiatry, University of Rostock, Rostock, Germany
  • 2Bayer Vital GmbH, Leverkusen, Germany
  • 3Clinic for Psychiatry, Psychotherapy and Psychosomatics, Queen Elisabeth Hospital, Herzberge, Berlin, Germany